Hansoh Pharmaceutical Group Co Ltd (3692.HK)
Company Info
Highlights
HK$140.92B
30.38
HK$15.17 - HK$25.90
HK$26.32
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Hansoh Pharmaceutical Group Co Ltd (3692.HK) returned 37.15% year-to-date (YTD) and 33.35% over the past 12 months.
3692.HK
37.15%
7.97%
36.52%
33.35%
-4.15%
N/A
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 3692.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 3.36% | 0.90% | 35.96% | -1.63% | -1.66% | 37.15% | |||||||
| 2024 | -25.63% | 17.75% | 12.17% | 12.40% | -7.70% | 2.46% | 4.66% | 16.86% | 6.02% | -13.41% | 6.39% | -10.47% | 11.67% |
| 2023 | 8.09% | -12.10% | -3.26% | 4.69% | -9.24% | -2.41% | 0.00% | -19.05% | 6.00% | 38.27% | 7.33% | -0.38% | 8.11% |
| 2022 | -15.58% | 4.24% | -21.53% | -0.76% | 8.60% | 12.79% | -3.41% | 2.61% | -20.60% | -2.42% | 21.78% | 0.54% | -21.07% |
| 2021 | 12.77% | -6.84% | -5.70% | -9.93% | 0.89% | 0.68% | -18.09% | -23.70% | -6.82% | -12.22% | -8.40% | 19.35% | -49.35% |
| 2020 | 8.11% | -3.39% | -2.77% | 14.45% | 11.79% | 8.47% | -8.22% | 9.70% | 2.45% | -8.23% | 7.81% | 0.94% | 45.17% |
| 2019 | 5.90% | 2.91% | 24.94% | -9.60% | -0.42% | -3.35% | 12.12% | 32.82% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 79, 3692.HK is among the top 21% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Hansoh Pharmaceutical Group Co Ltd (3692.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Hansoh Pharmaceutical Group Co Ltd provided a 1.45% dividend yield over the last twelve months, with an annual payout of HK$0.34 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Dividend | HK$0.34 | HK$0.34 | HK$0.19 | HK$0.14 | HK$0.08 |
Dividend yield | 1.45% | 1.99% | 1.21% | 0.94% | 0.41% |
Monthly Dividends
The table displays the monthly dividend distributions for Hansoh Pharmaceutical Group Co Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.20 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.34 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.14 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.19 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.09 | HK$0.00 | HK$0.00 | HK$0.05 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.14 |
| 2021 | HK$0.08 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.08 |
Dividend Yield & Payout
Dividend Yield
Hansoh Pharmaceutical Group Co Ltd has a dividend yield of 1.45%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Hansoh Pharmaceutical Group Co Ltd has a payout ratio of 42.97%, which is quite average when compared to the overall market. This suggests that Hansoh Pharmaceutical Group Co Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hansoh Pharmaceutical Group Co Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hansoh Pharmaceutical Group Co Ltd was 78.64%, occurring on Aug 21, 2023. The portfolio has not yet recovered.
The current Hansoh Pharmaceutical Group Co Ltd drawdown is 45.24%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.64% | Jan 25, 2021 | 633 | Aug 21, 2023 | — | — | — |
| -21.59% | Sep 4, 2019 | 67 | Dec 9, 2019 | 35 | Feb 3, 2020 | 102 |
| -20% | Jul 24, 2020 | 11 | Aug 7, 2020 | 101 | Jan 5, 2021 | 112 |
| -18.75% | Mar 9, 2020 | 11 | Mar 23, 2020 | 34 | May 14, 2020 | 45 |
| -15.81% | Jul 8, 2019 | 21 | Aug 5, 2019 | 14 | Aug 23, 2019 | 35 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hansoh Pharmaceutical Group Co Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Hansoh Pharmaceutical Group Co Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 3692.HK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 3692.HK has a P/E ratio of 30.4. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 3692.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 3692.HK has a P/S ratio of 11.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 3692.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 3692.HK has a P/B value of 4.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |